People: Bio-Rad Laboratories Inc (BIOb.N)
BIOb.N on New York Stock Exchange
115.50USD
21 May 2013
115.50USD
21 May 2013
Price Change (% chg)
$-1.26 (-1.08%)
$-1.26 (-1.08%)
Prev Close
$116.30
$116.30
Open
$115.50
$115.50
Day's High
$115.50
$115.50
Day's Low
$115.50
$115.50
Volume
200
200
Avg. Vol
39
39
52-wk High
$125.50
$125.50
52-wk Low
$93.98
$93.98
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Norman Schwartz |
63 | 2012 | Chairman of the Board, President, Chief Executive Officer |
Christine Tsingos |
54 | 2012 | Chief Financial Officer, Executive Vice President |
Sanford Wadler |
66 | 2012 | Executive Vice President, General Counsel, Secretary |
Bradford Crutchfield |
50 | 2012 | Executive Vice President, President, Life Science Group |
John Goetz |
63 | 2012 | Executive Vice President, President, Clinical Diagnostics Group |
Giovanni Magni |
56 | 2012 | Executive Vice President, International Sales Manager |
Ronald Hutton |
55 | 2012 | Vice President, Treasurer |
Alice Schwartz |
86 | 1967 | Director |
Louis Drapeau |
69 | 2007 | Independent Director |
Albert Hillman |
81 | 1980 | Independent Director |
Deborah Neff |
60 | 2011 | Independent Director |
Biographies
| Name | Description |
|---|---|
Norman Schwartz |
Mr. Norman D. Schwartz is Chairman of the Board, President, Chief Executive Officer of Bio Rad Laboratories Inc. Mr. Schwartz has been President and Chief Executive Officer since 2003 and Chairman of the Board since 2012. He was Vice President from 1989 to 2002, Group Manager, Life Science, from 1997 to 2002 and Group Manager, Clinical Diagnostics, from 1993 to 1997. |
Christine Tsingos |
Ms. Christine A. Tsingos is Chief Financial Officer, Executive Vice President of Bio Rad Laboratories Inc. Previously, she was the Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., a provider of information technology asset discovery and management tools, from August 2002 to November 2002. Prior to that, Ms. Tsingos was a consultant to Attest Systems, Inc. from October 2000 to July 2002. She was the Chief Financial Officer at Tavolo, Inc., an online retailer of gourmet cookware and food, from November 1999 to September 2000, and she was Treasurer, and later Vice President and Treasurer, of Autodesk, Inc., a developer of design software, from May 1990 to November 1999. |
Sanford Wadler |
Mr. Sanford S. Wadler is Executive Vice President, General Counsel, Secretary of Bio Rad Laboratories Inc. He served as General Counsel and Secretary since 1989 and was appointed Vice President in 1996 and Executive Vice President in 2012. |
Bradford Crutchfield |
Mr. Bradford J. Crutchfield is Executive Vice President, President, Life Science Group of Bio Rad Laboratories Inc. Previously, he held various positions within Bio-Rad since joining in 1985, including Managing Director, Bio-Rad Microscience, and Manager of BioMaterials Division. |
John Goetz |
Mr. John Goetz is Executive Vice President, President, Clinical Diagnostics Group of Bio Rad Laboratories Inc. Previously, he held various positions within Bio-Rad since joining in 1974 including Plant Engineer, Manufacturing Manager, Division Manager, Quality Systems Division and Operations Manager of the Diagnostics Group. |
Giovanni Magni |
Mr. Giovanni Magni is Executive Vice President, International Sales Manager of Bio Rad Laboratories Inc. Previously, he held various positions within Bio-Rad since joining in 1995, including Diagnostic Division Manager, Southern Europe and Diagnostics Group Operation Manager, France. |
Ronald Hutton |
Mr. Ronald W. Hutton is Vice President, Treasurer of Bio Rad Laboratories Inc. He has been Treasurer since 1997 and was appointed Vice President in 2012. Previously, he was Director of Treasury at Kaiser Aluminum & Chemical Corporation from 1993 to 1997. |
Alice Schwartz |
Mrs. Alice N. Schwartz is Director of Bio Rad Laboratories Inc. Mrs. Schwartz has been retired since 1979. From 1972 to 1978 she was a Research Associate at the University of California. As a co-founder of the Company, Mrs. Schwartz has a unique and invaluable understanding of Company’s business practices and core values. |
Louis Drapeau |
Mr. Louis Drapeau is Independent Director of Bio Rad Laboratories Inc. Mr. Drapeau is currently Vice President and Chief Financial Officer of InSite Vision and was Chief Executive Officer of InSite Vision from 2008 to 2010. From 2006 to 2007, he was Senior Vice President and Chief Financial Officer of Nektar Therapeutics. From 2004 to 2005 he was Acting Chief Executive Officer, and from 2002 to 2005 Senior Vice President and Chief Financial Officer, of BioMarin Pharmaceutical. From 1971 to 2002 he was with Arthur Andersen, where he was a Partner from 1983 to 2002 and Managing Partner from 1985 to 1997. He is also a Board member of Intermune, Inc. and AmpliPhi Biosciences Corp., and was a Board member of Inflazyme Pharmaceuticals Ltd. from 2006 to 2008 and of Bionovo, Inc. from 2007 to 2012. |
Albert Hillman |
Mr. Albert J. Hillman is Independent Director of Bio Rad Laboratories Inc. Mr. Hillman retired from active practice as an attorney in 1996. He was Of Counsel to the law firm of Townsend and Townsend and Crew from 1995 through 2005 and a partner in the firm from 1965 to 1995, which firm serves as patent counsel. |
Deborah Neff |
Ms. Deborah J. Neff serves as Independent Director of Bio Rad Laboratories Inc., since October 26, 2011. Ms. Neff is currently an executive advisor in the health care industry. From 2006 to 2012, she was President and Chief Executive Officer of Pathwork Diagnostics, Inc. From 2003 to 2006, she was the Chief Executive Officer of Predicant Biosciences. From 1988 to 2003, she served in various positions at BD Biosciences, including as worldwide President from 1995 to 2003. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Norman Schwartz |
4,520,750 |
Christine Tsingos |
825,846 |
Sanford Wadler |
663,774 |
Bradford Crutchfield |
786,453 |
John Goetz |
1,159,850 |
Giovanni Magni |
815,559 |
Ronald Hutton |
-- |
Alice Schwartz |
-- |
Louis Drapeau |
-- |
Albert Hillman |
-- |
Deborah Neff |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Norman Schwartz |
228,622 | 4,269,814 |
Christine Tsingos |
25,692 | 730,525 |
Sanford Wadler |
57,608 | 2,357,754 |
Bradford Crutchfield |
8,000 | 583,560 |
John Goetz |
71,507 | 3,084,535 |
Giovanni Magni |
0 | 0 |
Ronald Hutton |
0 | 0 |
Alice Schwartz |
0 | 0 |
Louis Drapeau |
0 | 0 |
Albert Hillman |
0 | 0 |
Deborah Neff |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
GOETZ JOHN |
10,000 | $35.50 |
SCHWARTZ NORMAN D |
61,487 | $36.00 |
SCHWARTZ NORMAN D |
39,889 | $105.50 |
MAGNI GIOVANNI |
5,404 | $103.85 |
MAGNI GIOVANNI |
5,605 | $35.50 |
MAGNI GIOVANNI |
201 | $104.76 |
SCHWARTZ NORMAN D |
120 | $0.00 |
SCHWARTZ ALICE N |
3,000 | $88.48 |
SCHWARTZ ALICE N |
8,227 | $56.40 |
SCHWARTZ ALICE N |
2,000 | $75.38 |
SCHWARTZ ALICE N |
7,608 | $53.50 |
SCHWARTZ ALICE N |
720 | $0.00 |
SCHWARTZ ALICE N |
8,000 | $36.00 |
SCHWARTZ ALICE N |
24,014 | $104.85 |
SCHWARTZ NORMAN D |
120 | $0.00 |
SCHWARTZ ALICE N |
4,000 | $75.00 |
SCHWARTZ STEVEN D |
120 | $0.00 |
SCHWARTZ ALICE N |
8,413 | $63.00 |
SCHWARTZ ALICE N |
1,000 | $84.57 |
SCHWARTZ STEVEN D |
120 | $0.00 |
TSINGOS CHRISTINE A |
200 | $0.00 |
CRUTCHFIELD BRADFORD J |
240 | $0.00 |
MAGNI GIOVANNI |
240 | $0.00 |
HUTTON RONALD W |
140 | $0.00 |
WADLER SANFORD SAUL |
200 | $0.00 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
